Tailored radiotherapeutic strategies for disseminated uterine cervical cancer patients.

PubWeight™: 0.75^‹?›

🔗 View Article (PMC 4394394)

Published in Radiat Oncol on April 04, 2015

Authors

Jung Ho Im¹, Hong In Yoon²^,3, Sunghoon Kim⁴, Eun Ji Nam⁵, Sang Wun Kim⁶, Ga Won Yim⁷, Ki Chang Keum⁸^,9, Young Tae Kim¹⁰, Gwi Eon Kim¹¹, Yong Bae Kim¹²^,13^,14

Author Affiliations

1: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. junghosta@naver.com.
2: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. yhi0225@yuhs.ac.
3: Department of Pharmacology, Yonsei University, College of Medicine, Seoul, South Korea. yhi0225@yuhs.ac.
4: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. shkim70@yuhs.ac.
5: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. nahmej6@yuhs.ac.
6: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. san1@yuhs.ac.
7: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. oceanblu@yuhs.ac.
8: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. kckeum@yuhs.ac.
9: Yonsei Song-Dang Institute for Cancer Research, Yonsei University, College of Medicine, Seoul, South Korea. kckeum@yuhs.ac.
10: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. ytkchoi@yuhs.ac.
11: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. gekim@yuhs.ac.
12: Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University, College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. ybkim3@yuhs.ac.
13: Women's Cancer Clinic, Yonsei Cancer Center, Yonsei University, College of Medicine, Seoul, South Korea. ybkim3@yuhs.ac.
14: Yonsei Song-Dang Institute for Cancer Research, Yonsei University, College of Medicine, Seoul, South Korea. ybkim3@yuhs.ac.

Articles cited by this ↗

Cervical cancer. Lancet (2003) 4.05

Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med (2014) 4.01

Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol (2004) 3.85

Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. J Clin Oncol (2002) 2.99

Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol (2011) 2.92

Phase III trial of four cisplatin-containing doublet combinations in stage IVB, recurrent, or persistent cervical carcinoma: a Gynecologic Oncology Group study. J Clin Oncol (2009) 2.82

Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet (2006) 2.47

Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study. Cancer (2006) 1.46

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer. Gynecol Oncol (2014) 1.14

Imaging in cervical cancer. Cancer (2003) 1.08

Supraclavicular lymph node metastases in cervical cancer. Eur J Gynaecol Oncol (2007) 0.99

Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. Gynecol Oncol (2008) 0.93

Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiat Oncol (2012) 0.93

Curative chemoradiotherapy in patients with stage IVB cervical cancer presenting with paraortic and left supraclavicular lymph node metastases. Int J Radiat Oncol Biol Phys (2012) 0.92

Palliative radiotherapy for cervical carcinoma, a systematic review. Radiother Oncol (2011) 0.89

Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer. Radiat Oncol (2013) 0.87

Short-course palliative radiotherapy for uterine cervical cancer. Radiat Oncol J (2013) 0.85

Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé? Gynecol Oncol (1999) 0.84

Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat Med (2006) 0.83

The type of metastasis is a prognostic factor in disseminated cervical cancer. J Gynecol Oncol (2010) 0.82

Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer with Distant Lymphatic Metastasis. Cancer Res Treat (2013) 0.81

Radiation therapy with chemotherapy for patients with cervical cancer and supraclavicular lymph node involvement. J Gynecol Oncol (2012) 0.81

Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasis. Radiat Oncol (2015) 0.80

Docetaxel, carboplatin and 5-fluorouracil (TCF) chemotherapy in patients with unresectable metastatic carcinoma of cervix. Gynecol Oncol (2010) 0.78

Outcomes and toxicities for the treatment of stage IVB cervical cancer. Arch Gynecol Obstet (2011) 0.78